CTNNB1 and neoplasm: Loss-of-function mutations in the oncosuppressor APC, mutations in CTNNB1 (β-Catenin gene), and the excessive presence of Wnt ligands in the tumor microenvironment (TME) disrupt these regulatory mechanisms, resulting in uncontrolled tumor growth [30,31].